Fig. 1From: Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced ratsExperimental groups and treatment schedules. AS-IV: Astragaloside IV; STZ: streptozotocin; CMC: carboxymethyl cellulose; Na-Citrate: sodium citrateBack to article page